| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/21/2006 | US7015021 Method for making purified plasminogen activator-inhibitor type 1 (PAI-1) and purified PAI-1 made therefrom |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/16/2006 | WO2006027468A2 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057662 Membrane scaffold proteins |
| 03/16/2006 | US20060057636 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1370589B1 Rationally designed antibodies |
| 03/15/2006 | EP1364030B1 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 03/15/2006 | EP1342730B1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 03/15/2006 | EP1294893B1 Modification of hepatitis b core antigen |
| 03/15/2006 | EP1233783B9 Hbv/hcv virus-like particle |
| 03/15/2006 | EP0942973B1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 03/15/2006 | EP0784477B1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1245512C Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011967 Seripancrin |
| 03/14/2006 | CA1341501C Vectors for the expression and segregation of hirudine by transformed yeasts |
| 03/09/2006 | WO2005063820A3 Il-7 fusion proteins |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060051843 Fluorescent protein for use as resolution tools in genetic analysis |
| 03/09/2006 | US20060051840 Hybrid expression of neisserial proteins |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051365 Immunogenic composition |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/08/2006 | EP1632574A1 Fibroblast growth factor homologs |
| 03/08/2006 | EP1632499A2 Gene sequences amplified in tumours and their diagnostic uses |
| 03/08/2006 | EP1631592A2 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 03/08/2006 | EP1294908B1 Method for improving transfection efficiency |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1265990B1 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP0870039B1 Recombinant fusion proteins to growth hormone and serum albumin |
| 03/08/2006 | CN1745098A Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 03/07/2006 | US7008925 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as immunomodulators and to affect motivation, learning, memory, behaviour, inflammation, body temperature, pain, perception |
| 03/07/2006 | US7008781 Method of enhancing the biological activity of ligands |
| 03/07/2006 | US7008780 Chimeric DNA-binding proteins |
| 03/02/2006 | WO2006022343A1 Gonadotropic hormone originating in invertebrate and method of producing the same |
| 03/02/2006 | WO2006000448A3 Fc-INTERFERON-BETA FUSION PROTEINS |
| 03/02/2006 | CA2578136A1 Gonadotropic hormone originating in invertabrate and method of producing the same |
| 03/01/2006 | EP1630171A1 Streptavidin binding peptides |
| 03/01/2006 | EP0941315B1 Fusion proteins containing stress proteins for inducing immune responses |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | CN1740325A A fusion gene, it expressed protein and producing process thereof |
| 03/01/2006 | CN1740200A Cervical cancer inhibiting fusion protein |
| 03/01/2006 | CN1243569C Use of active P40 conjugates for nasal delivery |
| 02/28/2006 | US7005511 Fluorescent protein variants and methods for making same |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040356 Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
| 02/23/2006 | US20060039922 Streptococcal heat shock proteins of the Hsp60 family |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | CA2576083A1 Protein production method utilizing yebf |
| 02/22/2006 | EP1627885A1 Polypeptide capable of assisting digestive organ absorption |
| 02/22/2006 | EP1626989A2 Method of treating corneal transplant rejection by using vegf antagonists |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | CN1737150A Adiponectin-Glucagon-like peptide-1-like peptide recombinant protein expression vector and construction |
| 02/22/2006 | CN1737012A Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/21/2006 | US7001986 Fluorescent proteins |
| 02/21/2006 | US7001747 Where the polylinker has multiple restriction enzyme sites in place of one or more polyketide sythase (PKS) genes encoding enzymes associated with reduction; vectors, host cells; biosynthesis of B1 avermectin |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | CA2098959C Compounds and methods for the site-specific photoaffinity labelling of biomolecules |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | WO2005070959A3 Compositions comprising immune response altering agents and methods of use |
| 02/16/2006 | US20060036078 Fluorescent proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060035265 In vitro selection and optional indentification of polypeptides using solid support carriers |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034852 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 02/16/2006 | US20060034836 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 02/16/2006 | CA2570324A1 Rage fusion proteins and methods of use |
| 02/15/2006 | EP1626084A1 Compositions and methods for the diagnosis of tumours |
| 02/15/2006 | EP1626058A1 Compositions and methods for the diagnosis of tumour |
| 02/15/2006 | EP1625161A1 A synthetic bioelastomer |
| 02/15/2006 | EP1625160A1 A bioelastomer |
| 02/15/2006 | EP1625152A2 Peptides modulating the activity of the engrailed transcription factor |
| 02/15/2006 | EP1624884A2 Somatostatin vectors |
| 02/15/2006 | EP1578802A4 Dna/rna transduction technology and its clinical and basic applications |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1733807A Fusion protein possessing growth facilitation action and its coding gene and uses |
| 02/15/2006 | CN1733806A Polypeptide random library and its construction method, and method for screening polypeptide capable of penetrating cell from the library |
| 02/15/2006 | CN1241946C Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 02/15/2006 | CN1241945C Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |